Athanasios Alexopoulos
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 4
-
- Probiotics and Fermented Foods 3
- Co-authors
- Michalis Leotsinidis (3 shared papers)Vassilis Georgoulias (2 shared papers)Xanthi Tsiafaki (1 shared paper)Ph. Palamidas (1 shared paper)A. Rapti (1 shared paper)Marinos Veslemes (1 shared paper)Emmanuel D. Papadakis (1 shared paper)Ioannis G. Vlachonikolis (1 shared paper)
- Journals
- Annals of Oncology (7 papers)European Journal of Cancer (2 papers)Oncology (2 papers)The Lancet (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- GreeceUnited KingdomFrance
In The Last Decade
Athanasios Alexopoulos
40 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 110
- Oncology 415
- Pulmonary and Respiratory Medicine 264
- Cancer Research 115
- Health, Toxicology and Mutagenesis 101
- Food Science 123
Countries citing papers authored by Athanasios Alexopoulos
This map shows the geographic impact of Athanasios Alexopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios Alexopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios Alexopoulos more than expected).
Fields of papers citing papers by Athanasios Alexopoulos
This network shows the impact of papers produced by Athanasios Alexopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios Alexopoulos. The network helps show where Athanasios Alexopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside Athanasios Alexopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 296 | |
| 2 | 2005 | 143 | |
| 3 | 2015 | 124 | |
| 4 | 1999 | 87 | |
| 5 | 2005 | 56 | |
| 6 | 2004 | 43 | |
| 7 | 2003 | 42 | |
| 8 | 1999 | 34 | |
| 9 | 2015 | 28 | |
| 10 | 2000 | 28 | |
| 11 | 2018 | 24 | |
| 12 | 2003 | 17 | |
| 13 | 2020 | 15 | |
| 14 | 1999 | 12 | |
| 15 | 2022 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2015 | 10 | |
| 18 | 2020 | 7 | |
| 19 | 2006 | 7 | |
| 20 | 2005 | 7 |
About Athanasios Alexopoulos
Athanasios Alexopoulos is a scholar working on Oncology, Food Science, Cancer Research, Pollution and Molecular Medicine, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (4 papers), Breast Cancer Treatment Studies (3 papers), Probiotics and Fermented Foods (3 papers), Data Stream Mining Techniques (2 papers), Identification and Quantification in Food (2 papers), Cloud Computing and Resource Management (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Oncology (415 citations), Pulmonary and Respiratory Medicine (264 citations), Cancer Research (115 citations), Health, Toxicology and Mutagenesis (101 citations) and Food Science (123 citations). Athanasios Alexopoulos has collaborated with scholars based in Greece, United Kingdom and France. Frequent co-authors include Michalis Leotsinidis, Vassilis Georgoulias, Xanthi Tsiafaki, Ph. Palamidas, A. Rapti, Marinos Veslemes, Emmanuel D. Papadakis, Ioannis G. Vlachonikolis, G. Rigatos and Alexandros S Ardavanis. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Oncology, The Lancet and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.